nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetirizine—Pruritus—Teniposide—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cetirizine—Arrhythmia—Carmustine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cetirizine—Cystitis—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Cetirizine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Cetirizine—Alopecia—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cetirizine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cetirizine—Mental disorder—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cetirizine—Vaginal infection—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Cetirizine—Cough—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Cetirizine—Diarrhoea—Teniposide—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cetirizine—Chest pain—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Cetirizine—Myalgia—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Cetirizine—Alopecia—Vincristine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cetirizine—Back pain—Carmustine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cetirizine—Discomfort—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cetirizine—Mental disorder—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cetirizine—Chills—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cetirizine—Bladder pain—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cetirizine—Urine output increased—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cetirizine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cetirizine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cetirizine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cetirizine—Confusional state—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cetirizine—Vision blurred—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cetirizine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cetirizine—Tremor—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cetirizine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cetirizine—Oedema—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cetirizine—Infection—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Cetirizine—Back pain—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Cetirizine—Vomiting—Teniposide—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cetirizine—Agitation—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cetirizine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cetirizine—Asthenia—Fludarabine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cetirizine—Rash—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cetirizine—Dermatitis—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cetirizine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cetirizine—Headache—Teniposide—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cetirizine—Pruritus—Fludarabine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cetirizine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cetirizine—Back pain—Mitoxantrone—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cetirizine—Anorexia—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Cetirizine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cetirizine—Agitation—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cetirizine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cetirizine—Polyuria—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cetirizine—Hypotension—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cetirizine—Diarrhoea—Fludarabine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Cetirizine—Convulsion—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Cetirizine—Hypertension—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Cetirizine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cetirizine—Nausea—Teniposide—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cetirizine—Vertigo—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cetirizine—Chest pain—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cetirizine—Myalgia—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cetirizine—Anxiety—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cetirizine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cetirizine—Malaise—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cetirizine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Cetirizine—Convulsion—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Cetirizine—Hypertension—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Cetirizine—Confusional state—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Cetirizine—Oedema—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cetirizine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cetirizine—Myalgia—Vincristine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cetirizine—Visual disturbance—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cetirizine—Cough—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cetirizine—Infection—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cetirizine—Vomiting—Fludarabine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cetirizine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cetirizine—Rash—Fludarabine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cetirizine—Dermatitis—Fludarabine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cetirizine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cetirizine—Pain—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cetirizine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cetirizine—Headache—Fludarabine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cetirizine—Tachycardia—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cetirizine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cetirizine—Myalgia—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cetirizine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cetirizine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cetirizine—Discomfort—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cetirizine—Oedema—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cetirizine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cetirizine—Anorexia—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cetirizine—Infection—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cetirizine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cetirizine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cetirizine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cetirizine—Nervous system disorder—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cetirizine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cetirizine—Hypotension—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cetirizine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Cetirizine—Oedema—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Cetirizine—Nausea—Fludarabine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Cetirizine—Infection—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Cetirizine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Cetirizine—Shock—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cetirizine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cetirizine—Urticaria—Bleomycin—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cetirizine—Anorexia—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cetirizine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cetirizine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cetirizine—Insomnia—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cetirizine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cetirizine—Irritability—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cetirizine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cetirizine—Paraesthesia—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cetirizine—Mood swings—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cetirizine—Hypotension—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cetirizine—Dyspnoea—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cetirizine—Somnolence—Carmustine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cetirizine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cetirizine—Ataxia—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cetirizine—Decreased appetite—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cetirizine—Hypotension—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cetirizine—Insomnia—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cetirizine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cetirizine—Paraesthesia—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cetirizine—Constipation—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Cetirizine—Pain—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Cetirizine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Cetirizine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Cetirizine—Decreased appetite—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cetirizine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cetirizine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cetirizine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cetirizine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cetirizine—Fatigue—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cetirizine—Asthenia—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cetirizine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cetirizine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cetirizine—Pain—Vincristine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cetirizine—Constipation—Vincristine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cetirizine—Pruritus—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cetirizine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cetirizine—Fatigue—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cetirizine—Pain—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cetirizine—Constipation—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cetirizine—Abdominal pain—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cetirizine—Body temperature increased—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cetirizine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cetirizine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cetirizine—Dysuria—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cetirizine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cetirizine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cetirizine—Body temperature increased—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cetirizine—Abdominal pain—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cetirizine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cetirizine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cetirizine—Hypersensitivity—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cetirizine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cetirizine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cetirizine—Pneumonia—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cetirizine—Vomiting—Bleomycin—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cetirizine—Rash—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cetirizine—Dermatitis—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cetirizine—Asthenia—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cetirizine—Stomatitis—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cetirizine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cetirizine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Cetirizine—Haematuria—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cetirizine—Epistaxis—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cetirizine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cetirizine—Asthenia—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cetirizine—Diarrhoea—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cetirizine—Nausea—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cetirizine—Asthenia—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Cetirizine—Dizziness—Carmustine—lymphatic system cancer	0.000992	0.000992	CcSEcCtD
Cetirizine—Diarrhoea—Vincristine—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Cetirizine—Hepatitis—Methotrexate—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Cetirizine—Pharyngitis—Methotrexate—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Cetirizine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Cetirizine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000958	0.000958	CcSEcCtD
Cetirizine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Cetirizine—Vomiting—Carmustine—lymphatic system cancer	0.000953	0.000953	CcSEcCtD
Cetirizine—Dizziness—Vincristine—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Cetirizine—Rash—Carmustine—lymphatic system cancer	0.000945	0.000945	CcSEcCtD
Cetirizine—Dermatitis—Carmustine—lymphatic system cancer	0.000945	0.000945	CcSEcCtD
Cetirizine—Visual impairment—Methotrexate—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
Cetirizine—Headache—Carmustine—lymphatic system cancer	0.000939	0.000939	CcSEcCtD
Cetirizine—Eye disorder—Methotrexate—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Cetirizine—Tinnitus—Methotrexate—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Cetirizine—Vomiting—Vincristine—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Cetirizine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000907	0.000907	CcSEcCtD
Cetirizine—Rash—Vincristine—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Cetirizine—Dermatitis—Vincristine—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Cetirizine—Headache—Vincristine—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Cetirizine—Nausea—Carmustine—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Cetirizine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Cetirizine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000883	0.000883	CcSEcCtD
Cetirizine—Rash—Mitoxantrone—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Cetirizine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Cetirizine—Chills—Methotrexate—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Cetirizine—Headache—Mitoxantrone—lymphatic system cancer	0.000873	0.000873	CcSEcCtD
Cetirizine—Alopecia—Methotrexate—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Cetirizine—Mental disorder—Methotrexate—lymphatic system cancer	0.000856	0.000856	CcSEcCtD
Cetirizine—Nausea—Vincristine—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Cetirizine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000833	0.000833	CcSEcCtD
Cetirizine—Nausea—Mitoxantrone—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Cetirizine—Back pain—Methotrexate—lymphatic system cancer	0.000823	0.000823	CcSEcCtD
Cetirizine—Vision blurred—Methotrexate—lymphatic system cancer	0.000802	0.000802	CcSEcCtD
Cetirizine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00079	0.00079	CcSEcCtD
Cetirizine—Malaise—Methotrexate—lymphatic system cancer	0.000767	0.000767	CcSEcCtD
Cetirizine—Vertigo—Methotrexate—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Cetirizine—Cough—Methotrexate—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Cetirizine—Convulsion—Methotrexate—lymphatic system cancer	0.000737	0.000737	CcSEcCtD
Cetirizine—Myalgia—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Cetirizine—Arthralgia—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Cetirizine—Chest pain—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Cetirizine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Cetirizine—Discomfort—Methotrexate—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Cetirizine—Confusional state—Methotrexate—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Cetirizine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Cetirizine—Infection—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Cetirizine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Cetirizine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Cetirizine—Skin disorder—Methotrexate—lymphatic system cancer	0.000675	0.000675	CcSEcCtD
Cetirizine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000671	0.000671	CcSEcCtD
Cetirizine—Anorexia—Methotrexate—lymphatic system cancer	0.000662	0.000662	CcSEcCtD
Cetirizine—Hypotension—Methotrexate—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Cetirizine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Cetirizine—Insomnia—Methotrexate—lymphatic system cancer	0.000628	0.000628	CcSEcCtD
Cetirizine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Cetirizine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000619	0.000619	CcSEcCtD
Cetirizine—Somnolence—Methotrexate—lymphatic system cancer	0.000617	0.000617	CcSEcCtD
Cetirizine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
Cetirizine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Cetirizine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.0006	0.0006	CcSEcCtD
Cetirizine—Fatigue—Methotrexate—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Cetirizine—Pain—Methotrexate—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Cetirizine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Cetirizine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000568	0.000568	CcSEcCtD
Cetirizine—Urticaria—Methotrexate—lymphatic system cancer	0.000552	0.000552	CcSEcCtD
Cetirizine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000549	0.000549	CcSEcCtD
Cetirizine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000549	0.000549	CcSEcCtD
Cetirizine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000512	0.000512	CcSEcCtD
Cetirizine—Asthenia—Methotrexate—lymphatic system cancer	0.000498	0.000498	CcSEcCtD
Cetirizine—Pruritus—Methotrexate—lymphatic system cancer	0.000491	0.000491	CcSEcCtD
Cetirizine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
Cetirizine—Dizziness—Methotrexate—lymphatic system cancer	0.000459	0.000459	CcSEcCtD
Cetirizine—Vomiting—Methotrexate—lymphatic system cancer	0.000442	0.000442	CcSEcCtD
Cetirizine—Rash—Methotrexate—lymphatic system cancer	0.000438	0.000438	CcSEcCtD
Cetirizine—Dermatitis—Methotrexate—lymphatic system cancer	0.000438	0.000438	CcSEcCtD
Cetirizine—Headache—Methotrexate—lymphatic system cancer	0.000435	0.000435	CcSEcCtD
Cetirizine—Nausea—Methotrexate—lymphatic system cancer	0.000413	0.000413	CcSEcCtD
